BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35083728)

  • 1. Angiotensin II Receptor Antagonist, Valsartan, Has Beneficial Effect in Lung Metastasis of Colorectal Cancer Treated with Fluorouracil.
    Asgharzadeh F; Naghibzadeh N; Hashemzehi M; Mostafapour A; Hassanian SM; Avan A; Khazaei M
    J Gastrointest Cancer; 2023 Mar; 54(1):126-134. PubMed ID: 35083728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiotensin pathway via valsartan reduces tumor growth in models of colorectal cancer.
    Asgharzadeh F; Mostafapour A; Ebrahimi S; Amerizadeh F; Sabbaghzadeh R; Hassanian SM; Fakhraei M; Farshbaf A; Ferns GA; Giovannetti E; Avan A; Khazaei M
    Toxicol Appl Pharmacol; 2022 Apr; 440():115951. PubMed ID: 35235860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of losartan in lung metastasis of colorectal cancer.
    Hashemzehi M; Naghibzadeh N; Asgharzadeh F; Mostafapour A; Hassanian SM; Ferns GA; Cho WC; Avan A; Khazaei M
    EXCLI J; 2020; 19():927-935. PubMed ID: 32665776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3.
    Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
    Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
    Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Wang CZ; Li XL; Sun S; Xie JT; Aung HH; Tong R; McEntee E; Yuan CS
    Anticancer Res; 2009 Aug; 29(8):2927-32. PubMed ID: 19661297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU.
    Sang J; Tang R; Yang M; Sun Q
    Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.
    Fujishima H; Kikuchi I; Miyanaga O; Ueda A; Baba E; Mitsugi K; Harada M; Nakano S
    Int J Clin Oncol; 2004 Apr; 9(2):92-7. PubMed ID: 15108040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats.
    Alqahtani F; Mohany M; Alasmari AF; Alanazi AZ; Belali OM; Ahmed MM; Al-Rejaie SS
    Int J Med Sci; 2020; 17(18):3098-3106. PubMed ID: 33173431
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma.
    Gebbia V; Testa A; Majello E; Cannata G; Tirrito ML; Mastrandrea G; Feo M; Bajardi G; Colucci G; Gebbia N
    Anticancer Drugs; 1996 Jun; 7(4):386-91. PubMed ID: 8826605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer.
    Schilsky RL; Bukowski R; Burris H; Hochster H; O'Rourke M; Wall JG; Mani S; Bonny T; Levin J; Hohneker J
    Ann Oncol; 2000 Apr; 11(4):415-20. PubMed ID: 10847459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
    Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
    Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
    Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
    J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
    Gul R; Alsalman N; Bazighifan A; Alfadda AA
    J Pharm Pharmacol; 2021 Oct; 73(11):1520-1529. PubMed ID: 34453839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.
    Thomaidis T; Maderer A; Formentini A; Bauer S; Trautmann M; Schwarz M; Neumann W; Kittner JM; Schad A; Link KH; Rey JW; Weinmann A; Hoffman A; Galle PR; Kornmann M; Moehler M
    J Exp Clin Cancer Res; 2014 Oct; 33(1):83. PubMed ID: 25272957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
    Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
    Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.